Zotefoams Valuation Multiples

Zotefoams is valued at $328M as of October 2026, a 1.6x revenue multiple. In the last 12 months, Zotefoams revenue was $248M and Zotefoams EBITDA was $50M.

Zotefoams Overview

About Zotefoams

Zotefoams PLC is engaged in the manufacturing of polymer foam using bespoke autoclave technology to produce foams with attributes. Its block foams are sold under the AZOTE, T-FIT, ZOTEK, and other brand names. The company serves automotive, aerospace, packaging, industrial parts, marine, building and construction, military, medical, and sports and leisure industries. It has three main operating segments Polyolefin foams, High-Performance Products, and MuCell Extrusion LLC. The maximum revenue to the company is generated from the High-Performance Products.


Founded

1992

HQ

United Kingdom

Employees

566

Financials (LTM)

Revenue: $248M
EBITDA: $50M

EV

$394M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Zotefoams Financials

Zotefoams reported last 12-month revenue of $248M and EBITDA of $50M.

In the same LTM period, Zotefoams generated $50M in EBITDA and $25M in net income.

Revenue (LTM)


Zotefoams P&L

In the most recent fiscal year, Zotefoams reported revenue of $211M and EBITDA of $40M.

Zotefoams is profitable as of last fiscal year, with gross margin of 33%, EBITDA margin of 19%, and net margin of 14%.

See analyst estimates for Zotefoams
LTMLast FY202320242025202620272028
Revenue$248M$211M$172M$200M$211M
Gross Profit-$70M$56M$62M$70M
Gross Margin-33%32%31%33%
EBITDA$50M$40M$32M$17M$40M
EBITDA Margin20%19%19%8%19%
EBIT Margin15%14%12%12%14%
Net Profit$25M$30M$13M($4M)$30M
Net Margin10%14%7%(2%)14%
Net Debt-$57M---

Financial data powered by Morningstar, Inc.

Zotefoams Stock Performance

Zotefoams has current market cap of $328M, and enterprise value of $394M.

Market Cap Evolution


Zotefoams' stock price is $6.65.

Zotefoams share price increased by 14.0% in the last 30 days, and by 10.3% in the last year.

Zotefoams has an EPS (earnings per share) of $0.61.

See more trading valuation data for Zotefoams
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$394M$328M0.1%14.0%7.3%10.3%$0.61

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Zotefoams Valuation Multiples

Zotefoams trades at 1.6x EV/Revenue multiple, and 7.8x EV/EBITDA.

See NTM and 2027E valuation multiples for Zotefoams

EV / Revenue (LTM)


Zotefoams Financial Valuation Multiples

As of October 19, 2026, Zotefoams has market cap of $328M and EV of $394M.

Zotefoams has a P/E ratio of 13.0x.

LTMLast FY202320242025202620272028
EV/Revenue1.6x1.9x2.3x2.0x1.9x
EV/EBITDA7.8x9.7x12.3x23.7x9.7x
EV/EBIT10.9x13.1x19.2x16.0x13.1x
EV/Gross Profit-5.6x7.1x6.3x5.6x
P/E13.0x10.9x26.2x(88.0x)10.9x
EV/FCF126.2x14.1xn/m25.6x14.1x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Zotefoams Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Zotefoams Margins & Growth Rates

Zotefoams grew revenue by 21% and EBITDA by 29% in the last fiscal year.

In the most recent fiscal year, Zotefoams reported gross margin of 33%, EBITDA margin of 19%, and net margin of 14%.

See estimated margins and future growth rates for Zotefoams

Zotefoams Margins

Last FY202420252026202720282029
Gross Margin33%31%33%-
EBITDA Margin19%8%19%20%
EBIT Margin14%12%14%15%
Net Margin14%(2%)14%10%
FCF Margin13%8%13%(1%)

Zotefoams Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth21%16%5%21%
Gross Profit Growth-12%13%-
EBITDA Growth29%(48%)143%29%
EBIT Growth25%20%22%25%
Net Profit Growth(16%)(130%)(908%)(16%)
FCF Growth(108%)(1717%)81%(108%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Zotefoams Operational KPIs

Zotefoams' revenue per employee in the last FY averaged $0.4M, while opex per employee averaged $0.1M for the same period.

Zotefoams' Rule of 40 is 42% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Zotefoams' Rule of X is 74% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Zotefoams
LTMLast FY202320242025202620272028
Rule of 4030%42%---
Bessemer Rule of X44%74%---
Revenue per Employee-$0.4M---
Opex per Employee-$0.1M---
S&M Expenses to Revenue-5%6%6%5%
G&A Expenses to Revenue13%14%14%13%14%
Opex to Revenue-19%20%19%19%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Zotefoams Competitors

Zotefoams competitors include Magnera, Aspen Aerogels, Alpha HPA, Canatu, Luxfer Holdings, Accsys, Alia Mentis, Metal Powder Works, REalloys and NanoXplore.

Most Zotefoams public comparables operate across Advanced Materials and DeepTech.

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
Magnera$3.2B$181M0.6x0.6x11.4x5.4x
Aspen Aerogels$271M($331M)1.5x1.7x(1.2x)(202.1x)
Alpha HPA$519K($28M)662.3x302.2x(12.3x)(11.8x)
Canatu$18M($10M)6.8x8.4x(12.5x)(6.9x)
Luxfer Holdings$385M$38M1.4x1.4x13.7x10.4x
Accsys$172M$15M1.3x1.3x14.9x9.2x
Alia Mentis$16M$10M9.9x-16.4x-
Metal Powder Works$1M($7M)132.3x41.2x(21.6x)(50.6x)

This data is available for Pro users. Sign up to see all Zotefoams competitors and their valuation data.

Start Free Trial

Acquisitions by Zotefoams

Zotefoams has acquired 2 companies to date.

Last acquisition by Zotefoams was on October 13th 2026. Zotefoams acquired Verttec for $5M (EV/Revenue multiple available to Pro users).

See M&A valuation multiples

Latest Acquisitions by Zotefoams

Verttec
KunShan ZOTEK King Lai Co. Ltd.
Description
Verttec is a manufacturer of irradiation cross-linked, closed-cell polyethylene foam (XLPE), sold under the i-Cell brand. The foams are made in several types for medical, industrial, transportation, aviation and recreation products. The company handles foam formulation, processing and quality assurance testing to meet customer-specific requirements, and offers technical guidance, quotes and samples. Customers are business buyers that incorporate the foam into their own products, and revenue comes from product sales. Verttec, LLC is based in Philadelphia, Pennsylvania, and was founded in 2021.
KunShan ZOTEK King Lai Co. Ltd. is a Kunshan-headquartered producer of closed-cell foam insulation products in Jiangsu Province, China. The company manufactures polyethylene and cross-linked foams for construction, automotive, and packaging applications, supplying domestic and international markets with thermal and shock-absorption materials.
HQ CountryUnited StatesChina
HQ City
Philadelphia, PA
Kunshan
Deal Date13 Oct 20266 Jan 2017
Valuation$5Mundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Zotefoams acquisitions and their M&A valuation multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Zotefoams

When was Zotefoams founded?Zotefoams was founded in 1992.
Where is Zotefoams headquartered?Zotefoams is headquartered in United Kingdom.
How many employees does Zotefoams have?As of today, Zotefoams has over 566 employees.
Who is the CEO of Zotefoams?Zotefoams' CEO is Ronan Michael Cox.
Is Zotefoams publicly listed?Yes, Zotefoams is a public company listed on London Stock Exchange.
What is the stock symbol of Zotefoams?Zotefoams trades under ZTF ticker.
When did Zotefoams go public?Zotefoams went public in 1995.
Who are competitors of Zotefoams?Zotefoams main competitors include Magnera, Aspen Aerogels, Alpha HPA, Canatu, Luxfer Holdings, Accsys, Alia Mentis, Metal Powder Works, REalloys, NanoXplore.
What is the current market cap of Zotefoams?Zotefoams' current market cap is $328M.
What is the current revenue of Zotefoams?Zotefoams' last 12 months revenue is $248M.
What is the current revenue growth of Zotefoams?Zotefoams revenue growth (NTM/LTM) is 9%.
What is the current EV/Revenue multiple of Zotefoams?Current revenue multiple of Zotefoams is 1.6x.
What is the current EBITDA of Zotefoams?Zotefoams' last 12 months EBITDA is $50M.
What is Zotefoams' EBITDA margin?Zotefoams' last 12 months EBITDA margin is 20%.
What is the current EV/EBITDA multiple of Zotefoams?Current EBITDA multiple of Zotefoams is 7.8x.
What is the current FCF of Zotefoams?Zotefoams' last 12 months FCF is $3M.
What is Zotefoams' FCF margin?Zotefoams' last 12 months FCF margin is 1%.
What is the current EV/FCF multiple of Zotefoams?Current FCF multiple of Zotefoams is 126.2x.
How many companies Zotefoams has acquired to date?As of October 2026, Zotefoams has acquired 2 companies.
What was the largest acquisition by Zotefoams?$5M acquisition of Verttec on 13th October 2026 was the largest M&A Zotefoams has done to date.
What companies Zotefoams acquired?Zotefoams acquired Verttec and KunShan ZOTEK King Lai Co. Ltd..
In how many companies Zotefoams has invested to date?Zotefoams hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Zotefoams

Lists including Zotefoams

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial